Psoriatic arthritis secondary prevention

Psoriatic arthritis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Psoriatic arthritis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgical Therapy
Primary prevention
Secondary prevention
Future or Investigational Therapies
Case Studies
Case #1
Psoriatic arthritis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Psoriatic arthritis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
National Guidelines Clearinghouse
NICE Guidance
FDA on Psoriatic arthritis secondary prevention
CDC on Psoriatic arthritis secondary prevention
Psoriatic arthritis secondary prevention in the news
Blogs onPsoriatic arthritis secondary prevention
Directions to Hospitals Treating Rheumatoid arthritis
Risk calculators and risk factors for Psoriatic arthritis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

Overview

There are no established secondary preventive measures for psoriatic arthritis.

Secondary prevention

• There are no established secondary preventive measures for psoriatic arthritis.
• Patients are monitored regularly for disease activity, drug efficacy, adverse effects and associated comorbid conditions.